ALIGOS THERAPEUTICS INC (ALGS)

US01626L1052 - Common Stock

0.8  -0.05 (-5.44%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
15.53M13.91M4.36M0.000.00
Operating Expenses
103.66M111.49M132.68M97.83M54.04M
Research and Development
73.04M85.08M104.15M79.89M43.35M
Selling, General, and Administrative Expenses
30.62M26.41M28.53M17.94M10.01M
Operating Income
-88.13M-97.58M-128.32M-97.83M-54.04M
Interest Income/Expense
4.30M1.52M240.00K1.26M1.56M
Other Income/Expense
-3.05M120.00K-110.00K-11.80M300.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-86.88M-95.94M-128.19M-108.38M-52.18M
Income Tax
795.00K110.00K140.00K160.00K90.00K
Net Income
-87.68M-96.05M-128.33M-108.54M-52.26M
EBITDA
-86.57M-95.27M-125.30M-95.09M-51.74M
 
Per Share Data
EPS Diluted Total Ops
-1.36-2.25-3.22-2.97-1.42
Non GAAP EPS
-1.59-2.26-3.20N/AN/A
 
Statistics
Profit Margin
-564.61%-690.51%-2943.35%N/AN/A
Operating Profit Margin
-567.50%-701.51%-2943.12%N/AN/A

All data in USD

Charts